Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.
European Medicines Agency
Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations.
Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
Trimesta in relapsing-remitting multiple sclerosis patients (Phase II)
Genmab announces positive top-line Phase II results of ofatumumab in multiple sclerosis
Biogen Reports Another Tecfidera PML Case
National Cancer Institute Search for Clinical Trials
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.
Generic interferon-beta
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
Thrombotic microangiopathy associated with interferon beta.
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.

Pages